Clinical Trial Update: Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial updates the use of darbepoetin alfa for treating anemia in adults on hemodialysis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia | Phase 3 | Status: COMPLETED